New onset atrial fibrilation and risk faktors in COVID-19

被引:23
|
作者
Kelesoglu, Saban [1 ]
Yilmaz, Yucel [2 ]
Ozkan, Eyup [2 ]
Calapkorur, Bekir [2 ]
Gok, Mustafa [2 ]
Dursun, Zehra Bestepe [3 ]
Kilic, Aysegul Ulu [4 ]
Demirelli, Selami [2 ]
Simsek, Ziya [2 ]
Elcik, Deniz [1 ]
机构
[1] Erciyes Univ, Dept Cardiol, Fac Med, Kayseri, Turkey
[2] Kayseri City Hosp, Dept Cardiol, Kayseri, Turkey
[3] Kayseri City Hosp, Dept Infect Dis, Kayseri, Turkey
[4] Erciyes Univ, Fac Med, Dept Infect Dis, Kayseri, Turkey
关键词
COVID-19; Arrhythmia; Atrial fibrillation; Inflammation; CHA2DS2-VASc score; FIBRILLATION;
D O I
10.1016/j.jelectrocard.2020.12.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: There is limited data concerning the prevalence of arrhythmias, particularly atrial fibrillation (AF), which may develop as a consequence of direct myocardial injury and the inflammatory state existing in COVID-19. Methods: This single-center study included data concerning 658 COVID-19 patients, who were hospitalized in our institute, between April 20th, 2020 and July 30th, 2020. Demographic data, findings of the imaging studies, and laboratory test results were retrieved from the institutional digital database. Results: New onset AF (NOAF) was identified in 33 patients (5%). Patients who developed AF were older (72.42 ? 6.10 vs 53.78 ? 13.80, p < 0.001) and had higher frequencies of hypertension and heart failure compared to patients without NOAF (p < 0.001, for both). The CHA2DS2-VASc score was higher in patients, who developed NOAF, compared to those who did not during hospitalization for COVID-19 (p < 0.001). Subjects, who developed NOAF during hospitalization, had a higher leukocyte count, neutrophil / lymphocyte ratio (NLR), C-reactive protein, erythrocyte sedimentation rate, and procalcitonin levels compared to those without NOAF (p < 0.001 for all comparisons). Diffuse lung infiltration was also more frequent in COVID-19 patients, who developed NOAF, during hospitalization (p = 0.015). Multivariate logistic regression analysis demonstrated that age, CHA2DS2-VASc score, CRP, erythrocyte sedimentation rate, and presence of diffuse lung infiltration on thorax CT were predictive for NOAF. Conclusion: The prevalence of NOAF in hospitalized COVID-19 patients is higher than the general population. Age, CHA2DS2-VASc score, C-reactive protein, erythrocyte sedimentation rate, and presence of diffuse lung infiltration on thorax CT may be used to identify patients at high risk for development of NOAF. Especially among these parameters, the presence of diffuse lung infiltration on thorax CT it was the most powerful independent predictor of NOAF development. ? 2020 Elsevier Inc. All rights reserved.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 50 条
  • [1] COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patients
    Jakob Wollborn
    Sergey Karamnov
    Kara G. Fields
    Tiffany Yeh
    Jochen D. Muehlschlegel
    Scientific Reports, 12
  • [2] COVID-19 increases the risk for the onset of atrial fibrillation in hospitalized patients
    Wollborn, Jakob
    Karamnov, Sergey
    Fields, Kara G.
    Yeh, Tiffany
    Muehlschlegel, Jochen D.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [3] PROGNOSTIC SIGNIFICANCE OF NEW-ONSET ATRIAL FIBRILLATION IN COVID-19
    Ko, Darae
    Treu, Timothy
    Tarko, Laura
    Ho, Yuk-Lam
    Galloway, Ashley
    Preis, Sarah
    Trinquart, Ludovic
    Gagnon, David
    Monahan, Kevin M.
    Helm, Robert
    Orkaby, Ariela R.
    Lubitz, Steven
    Walkey, Allan
    Cho, Kelly
    Wilson, Peter W.
    Benjamin, Emelia J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 21 - 21
  • [4] Incidence and Clinical Outcomes of New-Onset Atrial Fibrillation in Critically lll Patients with COVID-19: A Multicenter Cohort Study - New-Onset Atrial Fibrillation and COVID-19
    Kensara, Raed
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Alkofide, Hadeel
    Almohareb, Sumaya N.
    Alosaimi, Yousef S.
    Altebainawi, Ali F.
    Bin Saleh, Khalid
    Andas, Norah Al
    Harbi, Shmeylan Al
    Harthi, Abdullah F. Al
    Ashkan, Uhood
    Alghamdi, Rema
    Badreldin, Hisham A.
    Hafiz, Awatif
    AlFaifi, Mashael
    Alqahtani, Rahaf A.
    Vishwakarma, Ramesh
    Alenazi, Abeer A.
    Alalawi, Mai
    Mahboob, Reem
    Alfouzan, Renad A.
    Al Tuhayni, Layan B.
    Qahtani, Nouf Al
    Sulaiman, Khalid Al
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [5] COVID-19 AND NEW ONSET HYPERTENSION
    Shalaeva, Evgeniya
    Shamsutdinova, Maksuda
    Shadmanov, Alisher
    Boymuradov, Shukhrat
    Azizova, Feruza
    Allaberganov, Dilshod
    Saner, Hugo
    Messerli, Franz
    JOURNAL OF HYPERTENSION, 2022, 40 (SUPPL) : E28 - E29
  • [6] Is body mass index a risk factor for new onset atrial fibrilation in patients with acute coronary sindrome
    Boskovic, A.
    Vukmirovic, M.
    Nikolic, G.
    Vujosevic, S.
    Medenica, M.
    Orlandic, O.
    EUROPEAN JOURNAL OF HEART FAILURE, 2016, 18 : 206 - 206
  • [7] New-Onset Atrial Fibrillation and Multiple Systemic Emboli in a COVID-19 Patient
    Al-Abbas, Omar
    Alshaikhli, Alfarooq
    Amran, Hashed A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (01)
  • [8] New-Onset Diabetes in Covid-19
    Rubino, Francesco
    Amiel, Stephanie A.
    Zimmet, Paul
    Alberti, George
    Bornstein, Stefan
    Eckel, Robert H.
    Mingrone, Geltrude
    Boehm, Bernhard
    Cooper, Mark E.
    Chai, Zhonglin
    Del Prato, Stefano
    Ji, Linong
    Hopkins, David
    Herman, William H.
    Khunti, Kamlesh
    Mbanya, Jean-Claude
    Renard, Eric
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (08): : 789 - 790
  • [9] COVID-19 and new-onset arrhythmia
    Singh, Sandeep
    Desai, Rupak
    JOURNAL OF ARRHYTHMIA, 2020, 36 (03) : 547 - 548
  • [10] New-onset atrial fibrillation during COVID-19 infection predicts poor prognosis
    Pardo Sanz, Ana
    Salido Tahoces, Luisa
    Ortega Perez, Rodrigo
    Gonzalez Ferrer, Eduardo
    Sanchez Recalde, Angel
    Zamorano Gomez, Jose Luis
    CARDIOLOGY JOURNAL, 2021, 28 (01) : 34 - 40